Yingqi Xu

3.5k total citations · 1 hit paper
78 papers, 2.2k citations indexed

About

Yingqi Xu is a scholar working on Molecular Biology, Computer Networks and Communications and Electrical and Electronic Engineering. According to data from OpenAlex, Yingqi Xu has authored 78 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Computer Networks and Communications and 14 papers in Electrical and Electronic Engineering. Recurrent topics in Yingqi Xu's work include Energy Efficient Wireless Sensor Networks (14 papers), Mobile Ad Hoc Networks (9 papers) and RNA modifications and cancer (9 papers). Yingqi Xu is often cited by papers focused on Energy Efficient Wireless Sensor Networks (14 papers), Mobile Ad Hoc Networks (9 papers) and RNA modifications and cancer (9 papers). Yingqi Xu collaborates with scholars based in China, United States and Macao. Yingqi Xu's co-authors include Wang-Chien Lee, Xia Li, Meiwan Chen, Chengwei He, Peng Wang, Jing Bai, Congxue Hu, Hon Fai Chan, Yunpeng Zhang and Tengyue Li and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Journal of Applied Physics.

In The Last Decade

Yingqi Xu

75 papers receiving 2.2k citations

Hit Papers

CellMarker 2.0: an update... 2022 2026 2023 2024 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingqi Xu China 22 955 582 454 378 222 78 2.2k
Youjie Li China 27 875 0.9× 143 0.2× 615 1.4× 226 0.6× 122 0.5× 115 2.0k
Yi‐Hsuan Hsiao Taiwan 28 545 0.6× 320 0.5× 266 0.6× 719 1.9× 78 0.4× 120 2.8k
Youngsoo Kim South Korea 36 1.7k 1.8× 189 0.3× 312 0.7× 198 0.5× 374 1.7× 193 3.9k
Yujing Zhang China 34 2.6k 2.7× 180 0.3× 1.1k 2.5× 425 1.1× 257 1.2× 121 4.1k
Wei‐Chung Cheng Taiwan 33 2.0k 2.1× 182 0.3× 1.1k 2.4× 404 1.1× 371 1.7× 181 3.7k
Yunjie Zhao China 34 2.3k 2.4× 135 0.2× 450 1.0× 174 0.5× 377 1.7× 150 4.3k
Jianhui Chang China 26 1.3k 1.3× 166 0.3× 303 0.7× 629 1.7× 518 2.3× 76 3.8k
Liang Jin China 22 559 0.6× 356 0.6× 84 0.2× 268 0.7× 79 0.4× 148 2.1k
Xudong Shi United States 31 1.1k 1.2× 92 0.2× 161 0.4× 161 0.4× 105 0.5× 78 2.1k

Countries citing papers authored by Yingqi Xu

Since Specialization
Citations

This map shows the geographic impact of Yingqi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingqi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingqi Xu more than expected).

Fields of papers citing papers by Yingqi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingqi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingqi Xu. The network helps show where Yingqi Xu may publish in the future.

Co-authorship network of co-authors of Yingqi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingqi Xu. A scholar is included among the top collaborators of Yingqi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingqi Xu. Yingqi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Donghai, Yingqi Xu, Shilin Zhang, & Linping Wang. (2025). Construction of a 1D/0D/2D BiFeO 3 /Ag/g-C 3 N 4 Z-scheme heterojunction for enhanced visible light photocatalysis of methylene blue. RSC Advances. 15(38). 31508–31521.
2.
He, Shasha, Xiangbao Yin, Yingqi Xu, & Zhiwei Zhong. (2025). Rivaroxaban vs. Enoxaparin for Preventing Venous Thromboembolism and Wound Complications after Knee Surgery: A Meta-Analysis. Journal of College of Physicians And Surgeons Pakistan. 35(10). 1318–1324. 1 indexed citations
3.
Tao, Tao, et al.. (2025). Predicting diabetic retinopathy based on biomarkers: Classification and regression tree models. Diabetes Research and Clinical Practice. 222. 112091–112091. 1 indexed citations
4.
Bai, Jing, et al.. (2023). Multiscale integrative analyses unveil immune-related diagnostic signature for the progression of MASLD. Hepatology Communications. 7(11). 3 indexed citations
5.
Xu, Yanjun, Jingwen Wang, Feng Li, et al.. (2022). Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data. Computational and Structural Biotechnology Journal. 20. 838–849. 4 indexed citations
6.
Yan, Jie, Abdul Rehman, Yang An, et al.. (2022). Fentanyl enhances HIV infection in vitro. Virology. 577. 43–50. 3 indexed citations
7.
Liang, Wei, et al.. (2021). Key Genes and Prognostic Analysis in HER2+ Breast Cancer. Technology in Cancer Research & Treatment. 20. 1079250946–1079250946. 16 indexed citations
8.
Ma, Ying, Dongliang Li, Wenfeng Liu, et al.. (2021). Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis. Frontiers in Pharmacology. 12. 747625–747625. 9 indexed citations
9.
Wang, Li, Hongying Zhao, Jing Li, et al.. (2019). Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines. Oncogene. 39(3). 677–689. 11 indexed citations
10.
Xu, Yingqi, Shuting Lin, Hongying Zhao, et al.. (2019). Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients. Genes. 10(9). 657–657. 3 indexed citations
11.
Xu, Yingqi, Dingxin Liu, Jie Hu, Peirong Ding, & Meiwan Chen. (2019). Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment. International Journal of Pharmaceutics. 573. 118637–118637. 47 indexed citations
12.
Xu, Yingqi, Shengpeng Wang, Hon Fai Chan, et al.. (2017). Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria- targeted gambogic acid delivery. International Journal of Pharmaceutics. 522(1-2). 21–33. 46 indexed citations
14.
15.
Fang, Xiaobin, Yingqi Xu, Shengpeng Wang, et al.. (2016). Pluronic F68-Linoleic Acid Nano-spheres Mediated Delivery of Gambogic Acid for Cancer Therapy. AAPS PharmSciTech. 18(1). 147–155. 16 indexed citations
16.
Xu, Yingqi, et al.. (2008). Energy-Aware and Time-Critical Geo-Routing in Wireless Sensor Networks. International Journal of Distributed Sensor Networks. 4(4). 315–346. 3 indexed citations
17.
Xu, Yingqi & Wang-Chien Lee. (2007). Compressing Moving Object Trajectory in Wireless Sensor Networks. International Journal of Distributed Sensor Networks. 3(2). 151–174. 14 indexed citations
18.
Jin, Qingyuan, et al.. (1995). Spin wave resonance in CoCr/Cu/CoCr sandwiches. Journal of Magnetism and Magnetic Materials. 140-144. 1985–1986. 1 indexed citations
19.
Zhai, Hao, et al.. (1992). The magneto-optical Kerr effect of bilayers Fe/Au-Cu and Fe/Ag-Au. Journal of Applied Physics. 71(3). 1373–1375. 4 indexed citations
20.
Zhou, Shiming, et al.. (1990). Magneto-optical Kerr effect of NdFe films and NdFe/Cu bilayers. Solid State Communications. 76(11). 1305–1307. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026